glp-1 obesity drugs pipeline Top and Diabetes Medications Transforming U.S. Pharma Market Can Novo Nordisk's pipeline transform

a non-GLP-1 agonist show that overall, thyroid cancer is increased in people who take GLP-1s

Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes

J., Seino, Y., & Yamada, Y

This displacement shift raises concerns about a potential reduction in the radiation dose reaching the target cells, leading to apprehensions about inadvertently overdosing patients with radiation and chemotherapy [31, 32]

If your insurance doesnt cover GLP-1s, or if you dont have insurance, there are discounted options available through the pharmaceutical companies that manufacture the medications

doi:10.6061/clinics/2015(11)09